Vaxneuvance CPT Vaccine Code: 90671

Vaccine & Product Overview

HCPCS Descriptor Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use

Manufacturer Merck Sharp & Dohme Corp

Route of Administration Intramuscular

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Suspension

About Vaxneuvance

Vaxneuvance is a medication aligned to the HCPCS CPT Drug Code: 90671 for billing, pricing, and reimbursement purposes in the United States. This Vaccine medication is administered via the intramuscular route and manufactured by Merck Sharp & Dohme Corp.

According to CMS Drug Use Information: This vaccine is used to help prevent pneumococcal disease, an infection caused by a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infections or other more serious infections (such as pneumonia, meningitis, blood infection). Vaccination is the best way to protect against this disease. This vaccine works by increasing the body's natural defense (immunity) against the bacteria. Vaccines may not fully protect everyone who receives them.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

1 NDC package is crosswalked to 90671. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	Vaxneuvance

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Vaxneuvance Pricing & Reimbursement

90671 Private Payer Reimbursement

$273.81 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Vaxneuvance Vaccine Administration Codes

Medicare bills the administration of Vaxneuvance with HCPCS code G0009, and allows simplified roster billing when vaccinating multiple patients. The CPT codes below apply to non-Medicare payers.

Code	Description
G0009	Administration of pneumococcal vaccine (Medicare)
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472	Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

Vaxneuvance Medically Unlikely Edits (MUE)

The most billing units of 90671 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 ea.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

Vaxneuvance Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F

Drug Class

Actively Acquired Immunity [PE]Inactivated Pneumococcal Vaccine [EPC]Pneumococcal Vaccines [CS]VaccinesConjugate [CS]Inactivated [CS]

Frequently Asked Questions

Is there an available Vaxneuvance billing and coding guide?

Billing and coding information for Vaxneuvance can be found through Merck. Visit Here →

Are there any available Vaxneuvance patient assistance programs?

Vaxneuvance patient assistance information can be found through Merck. Visit Here →

Where can I find Vaxneuvance prescribing information?

Vaxneuvance prescribing information can be found at the link below: Visit Here →

Where can I find Vaxneuvance side effect information?

Information regarding Vaxneuvance's side effects can be found at MedlinePlus Visit Here →

Does billing Vaxneuvance require JZ/JW wastage modifiers?

CMS does not include Vaxneuvance (90671) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90671. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.